Patient Information

Smartphone apps, wearable devices, and other forms of digital technology that allow patients to monitor what they eat and how much they exercise are popular, but patients might find it difficult to differentiate between the wide range of products available.  In “Digital Health Technology for Weight Loss and Weight Maintenance,” the Obesity Society provides information to help patients decide if such devices are right for them. This guide, which is available at http://www.obesity.org/resources-for/digital-health-technology-for-weight-loss-and-weight-maintenance.htm, includes an overview of the types of apps and devices available and questions to consider before using one, such as “Would you be able to set up and use the digital health device without a lot of support?” and “Is using the digital health device fun?”

Smartphone apps, wearable devices, and other forms of digital technology that allow patients to monitor what they eat and how much they exercise are popular, but patients might find it difficult to differentiate between the wide range of products available.  In “Digital Health Technology for Weight Loss and Weight Maintenance,” the Obesity Society provides information to help patients decide if such devices are right for them. This guide, which is available at http://www.obesity.org/resources-for/digital-health-technology-for-weight-loss-and-weight-maintenance.htm, includes an overview of the types of apps and devices available and questions to consider before using one, such as “Would you be able to set up and use the digital health device without a lot of support?” and “Is using the digital health device fun?”

Smartphone apps, wearable devices, and other forms of digital technology that allow patients to monitor what they eat and how much they exercise are popular, but patients might find it difficult to differentiate between the wide range of products available.  In “Digital Health Technology for Weight Loss and Weight Maintenance,” the Obesity Society provides information to help patients decide if such devices are right for them. This guide, which is available at http://www.obesity.org/resources-for/digital-health-technology-for-weight-loss-and-weight-maintenance.htm, includes an overview of the types of apps and devices available and questions to consider before using one, such as “Would you be able to set up and use the digital health device without a lot of support?” and “Is using the digital health device fun?”

An online resource from the American Heart Association can help patients follow the instructions you’ve given them about their treatment for heart failure (HF). “How Can I Live with Heart Failure?” can be downloaded from http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300316.pdf. It describes medications used to treat HF, lists warning signs patients should immediately report, and provides a space for patients to write down your advice regarding medications, diet, and exercise.

An online resource from the American Heart Association can help patients follow the instructions you’ve given them about their treatment for heart failure (HF). “How Can I Live with Heart Failure?” can be downloaded from http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300316.pdf. It describes medications used to treat HF, lists warning signs patients should immediately report, and provides a space for patients to write down your advice regarding medications, diet, and exercise.

An online resource from the American Heart Association can help patients follow the instructions you’ve given them about their treatment for heart failure (HF). “How Can I Live with Heart Failure?” can be downloaded from http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300316.pdf. It describes medications used to treat HF, lists warning signs patients should immediately report, and provides a space for patients to write down your advice regarding medications, diet, and exercise.

The benefits of using glucagon-like peptide 1 receptor agonists to treat type 2 diabetes mellitus outweigh the risks, and there seems to be little reason to withhold this effective therapy except in patients who have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias type 2.

To read the full article, go to the Cleveland Clinic Journal of Medicine: http://www.ccjm.org/current-issue/issue-single-view/should-we-be-concerned-about-thyroid-cancer-in-patients-taking-glucagon-like-peptide-1-receptor-agonists/fb3ef956f5932e488eccca649368a555.html.

The benefits of using glucagon-like peptide 1 receptor agonists to treat type 2 diabetes mellitus outweigh the risks, and there seems to be little reason to withhold this effective therapy except in patients who have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias type 2.

To read the full article, go to the Cleveland Clinic Journal of Medicine: http://www.ccjm.org/current-issue/issue-single-view/should-we-be-concerned-about-thyroid-cancer-in-patients-taking-glucagon-like-peptide-1-receptor-agonists/fb3ef956f5932e488eccca649368a555.html.

The benefits of using glucagon-like peptide 1 receptor agonists to treat type 2 diabetes mellitus outweigh the risks, and there seems to be little reason to withhold this effective therapy except in patients who have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias type 2.

To read the full article, go to the Cleveland Clinic Journal of Medicine: http://www.ccjm.org/current-issue/issue-single-view/should-we-be-concerned-about-thyroid-cancer-in-patients-taking-glucagon-like-peptide-1-receptor-agonists/fb3ef956f5932e488eccca649368a555.html.

The National Institute of Mental Health offers a brief yet comprehensive e-brochure to teach patients the basics of depression. “Depression” is available at http://www.nimh.nih.gov/health/publications/depression/depression-booklet_34625.pdf. It explains the differences between various depressive disorders, discusses depression diagnosis and treatment, and offers suggestions on how to help a friend or loved one who is depressed.

The National Institute of Mental Health offers a brief yet comprehensive e-brochure to teach patients the basics of depression. “Depression” is available at http://www.nimh.nih.gov/health/publications/depression/depression-booklet_34625.pdf. It explains the differences between various depressive disorders, discusses depression diagnosis and treatment, and offers suggestions on how to help a friend or loved one who is depressed.

The National Institute of Mental Health offers a brief yet comprehensive e-brochure to teach patients the basics of depression. “Depression” is available at http://www.nimh.nih.gov/health/publications/depression/depression-booklet_34625.pdf. It explains the differences between various depressive disorders, discusses depression diagnosis and treatment, and offers suggestions on how to help a friend or loved one who is depressed.

If the pretest probability of deep vein thrombosis is low, a normal D-dimer level is enough to rule it out.

To read the full article, go to the Cleveland Clinic Journal of Medicine: http://www.ccjm.org/current-issue/issue-single-view/does-the-patient-need-ultrasonography-of-the-leg-to-evaluate-for-deep-vein-thrombosis/920380017b1df57c1c99c1194c3b136f.html.

If the pretest probability of deep vein thrombosis is low, a normal D-dimer level is enough to rule it out.

To read the full article, go to the Cleveland Clinic Journal of Medicine: http://www.ccjm.org/current-issue/issue-single-view/does-the-patient-need-ultrasonography-of-the-leg-to-evaluate-for-deep-vein-thrombosis/920380017b1df57c1c99c1194c3b136f.html.

If the pretest probability of deep vein thrombosis is low, a normal D-dimer level is enough to rule it out.

To read the full article, go to the Cleveland Clinic Journal of Medicine: http://www.ccjm.org/current-issue/issue-single-view/does-the-patient-need-ultrasonography-of-the-leg-to-evaluate-for-deep-vein-thrombosis/920380017b1df57c1c99c1194c3b136f.html.

In the online pamphlet “COPD: It can take your breath away,” patients will find easy-to-understand information about COPD pathophysiology, symptoms, diagnosis, and treatments, including lifestyle changes, medications, oxygen, and surgery. The pamphlet is written by physicians from Harvard Medical. It can be downloaded from http://www.patienteducationcenter.org/emedia/copd-brochure.

In the online pamphlet “COPD: It can take your breath away,” patients will find easy-to-understand information about COPD pathophysiology, symptoms, diagnosis, and treatments, including lifestyle changes, medications, oxygen, and surgery. The pamphlet is written by physicians from Harvard Medical. It can be downloaded from http://www.patienteducationcenter.org/emedia/copd-brochure.

In the online pamphlet “COPD: It can take your breath away,” patients will find easy-to-understand information about COPD pathophysiology, symptoms, diagnosis, and treatments, including lifestyle changes, medications, oxygen, and surgery. The pamphlet is written by physicians from Harvard Medical. It can be downloaded from http://www.patienteducationcenter.org/emedia/copd-brochure.